Medical Research and Clinical Trials

AstraZeneca Oncology Portfolio Shows Mixed Results: Enhertu and Tagrisso Shine, Etcamah Faces Setback

• Medical Research and Clinical Trials

AstraZeneca Oncology Portfolio Shows Mixed Results: Enhertu and Tagrisso Shine, Etcamah Faces Setback

Iffa Jayyana September 14, 2026

London, UK – October 26, 2026 – AstraZeneca, the UK-Swedish biopharmaceutical giant, has recently unveiled significant clinical...

Read More Read more about AstraZeneca Oncology Portfolio Shows Mixed Results: Enhertu and Tagrisso Shine, Etcamah Faces Setback

A New Dawn in Glioblastoma Treatment: Keck Medicine of USC Unveils Promising Combination Therapy

• Medical Research and Clinical Trials

A New Dawn in Glioblastoma Treatment: Keck Medicine of USC Unveils Promising Combination Therapy

Raul Delapena Setiawan September 14, 2026

LOS ANGELES, CA – A groundbreaking study spearheaded by researchers at Keck Medicine of USC has brought...

Read More Read more about A New Dawn in Glioblastoma Treatment: Keck Medicine of USC Unveils Promising Combination Therapy

J&J’s Rybrevant linked to longest median OS in exon 20 EGFR NSCLC

• Medical Research and Clinical Trials

J&J’s Rybrevant linked to longest median OS in exon 20 EGFR NSCLC

Dwi Wanna September 14, 2026

Seoul, Republic of South Korea – September 15, 2026 – In a significant advancement for the treatment...

Read More Read more about J&J’s Rybrevant linked to longest median OS in exon 20 EGFR NSCLC

Breakthrough Study Offers Hope for Breast Cancer Survivors by Targeting Dormant Cancer Cells

• Medical Research and Clinical Trials

Breakthrough Study Offers Hope for Breast Cancer Survivors by Targeting Dormant Cancer Cells

Reynand Wu September 14, 2026

Philadelphia, PA – In a landmark achievement that promises to redefine post-treatment care for breast cancer survivors,...

Read More Read more about Breakthrough Study Offers Hope for Breast Cancer Survivors by Targeting Dormant Cancer Cells

ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial

• Medical Research and Clinical Trials

ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial

Nana Wu September 14, 2026

To write a news article, I need actual news content, such as: Main Facts: Who, what, when,...

Read More Read more about ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial

Landmark Discovery Unlocks Secrets of Aggressive Brain Cancer, Offering Hope for Earlier Diagnosis and Smarter Treatments

• Medical Research and Clinical Trials

Landmark Discovery Unlocks Secrets of Aggressive Brain Cancer, Offering Hope for Earlier Diagnosis and Smarter Treatments

Reynand Wu September 13, 2026

London, UK – September 8, 2023 – In a groundbreaking revelation that could transform the fight against...

Read More Read more about Landmark Discovery Unlocks Secrets of Aggressive Brain Cancer, Offering Hope for Earlier Diagnosis and Smarter Treatments

BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

• Medical Research and Clinical Trials

BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

Ammar Sabilarrohman September 13, 2026

San Rafael, CA – October 26, 2023 – BioMarin Pharmaceutical Inc. has announced a significant milestone in...

Read More Read more about BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

ERS 2026: Phase Ib/IIa results support further evaluation of 9MW1911 in COPD

• Medical Research and Clinical Trials

ERS 2026: Phase Ib/IIa results support further evaluation of 9MW1911 in COPD

Basiran September 13, 2026

To create such an article, I would need actual news content, such as: Main Facts: Who, what,...

Read More Read more about ERS 2026: Phase Ib/IIa results support further evaluation of 9MW1911 in COPD

Breakthrough Discovery Links Age-Related Blood Cell Mutations in Tumours to Worse Cancer Outcomes

• Medical Research and Clinical Trials

Breakthrough Discovery Links Age-Related Blood Cell Mutations in Tumours to Worse Cancer Outcomes

Nana Wu September 13, 2026

London, UK / New York, USA – A groundbreaking collaborative study has unveiled a critical connection between...

Read More Read more about Breakthrough Discovery Links Age-Related Blood Cell Mutations in Tumours to Worse Cancer Outcomes

ERS 2026: Sanofi’s lunsekimig hits Phase IIb goals in asthma, Phase III set to follow

• Medical Research and Clinical Trials

ERS 2026: Sanofi’s lunsekimig hits Phase IIb goals in asthma, Phase III set to follow

Suro Senen September 13, 2026

To create a 1,200-word journalistic article with the specified structure and tone, I would need a substantial...

Read More Read more about ERS 2026: Sanofi’s lunsekimig hits Phase IIb goals in asthma, Phase III set to follow